Chronic obstructive pulmonary disease (COPD) management should take into account patients’ comorbidities, according to a poster presented at the Academy of Managed Care Pharmacy Nexus 2021 meeting.

In one poster, the investigators reviewed the US IQVIA claims database to identify claims, diagnoses, and treatments for patients with COPD who received treatment between September 2017 and August ...

Late Breaking Poster Presentation. Title: The safety and PK of an inhaled pan JAK inhibitor (KN-002) in subjects with COPD Session Title: Biological treatments for asthma: novel real-world and ...